Diabetes, Obesity & Hypertension 2018

Concenter BioPharma
Feb 1, 2018
1 min read

Updated: Dec 8, 2020

The 6th World Congress on Controversies to Consensus in Diabetes,

Obesity and Hypertension (CODHy) to be held in Tel Aviv, Israel,

February 21-22, 2018.

Come see our poster and talk to us about our upcoming submission of our IND for Treating Type 2 Diabetes. Looking forward to seeing you there.

READ MORE

Komentar

Hi, thanks for stopping by!

Concenter BioPharma is a subsidiary of Silkim Pharma Ltd., which developed a novel, protected PLATFORM of drugs for proven treatments of multiple indications.

Our PLATFORM is the result of extensive investigation of animal models of human diseases.

Concenter

BioPharma

Diabetes, Obesity & Hypertension 2018

The 6th World Congress on Controversies to Consensus in Diabetes,

Obesity and Hypertension (CODHy) to be held in Tel Aviv, Israel,

February 21-22, 2018.

Come see our poster and talk to us about our upcoming submission of our IND for Treating Type 2 Diabetes. Looking forward to seeing you there.

Recent Posts

Komentar

Hi, thanks for stopping by!

Let the news
come to you.

Concenter

BioPharma

The 6th World Congress on Controversies to Consensus in Diabetes,

Obesity and Hypertension (CODHy) to be held in Tel Aviv, Israel,

February 21-22, 2018.

Come see our poster and talk to us about our upcoming submission of our IND for Treating Type 2 Diabetes. Looking forward to seeing you there.

Komentar

Hi, thanks for stopping by!

Let the news come to you.

Let the news
come to you.